Ito, Mika
Takino, Naomi
Nomura, Takamasa
Kan, Akihiko
Muramatsu, Shin-ichi
Article History
Received: 18 September 2020
Accepted: 14 April 2021
First Online: 29 April 2021
Competing interests
: M.I., N.K., and S.M. are inventors on patents for AAV.GT5 used in this paper. S.M. owns equity in a gene therapy company (Gene Therapy Research Institution, Co., Ltd.) that commercializes the use of AAV vectors for gene therapy applications. T.N. and A.K are employees of a company that develops ELISA for AAV vectors.